Merck (MRK) Misses Q1 EPS by 23c, Offers FY Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $132.54 +4.36%
EPS Growth %: +47.9%
Financial Fact:
Net Income: 8.08B
Today's EPS Names:
DGICA, UXIN, TOWN, More
EPS Growth %: +47.9%
Financial Fact:
Net Income: 8.08B
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q1 EPS of $1.40, $0.23 worse than the analyst estimate of $1.63. Revenue for the quarter came in at $12.1 billion versus the consensus estimate of $12.66 billion.
GUIDANCE:
Merck sees FY2021 EPS of $6.48-$6.68, versus the consensus of $6.58. Merck sees FY2021 revenue of $51.8-53.8 billion, versus the consensus of $52.51 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck (MRK) Tops Q1 EPS by 14c, Beats on Revenue; Offers FY24 Guidance
- Union Pacific (UNP) Tops Q1 EPS by 18c
- West Bancorporation (WTBA) Tops Q1 EPS by 8c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
